Which feature best distinguishes morphine from fentanyl in terms of clinical pharmacokinetics and organ dependence?

## Morphine vs Fentanyl: Pharmacokinetic Distinction ### Metabolism and Elimination Pathways **Key Point:** The critical discriminator between morphine and fentanyl is their metabolic fate and organ dependence for clearance. | Feature | Morphine | Fentanyl | |---------|----------|----------| | **Primary metabolism** | Hepatic (Phase II glucuronidation) | Hepatic (CYP3A4) | | **Active metabolites** | M6G, M3G (renally eliminated) | Inactive metabolites | | **Organ dependence** | Renal (accumulation risk in renal failure) | Hepatic (accumulation risk in liver failure) | | **Duration of action** | 3–4 hours (IV) | 30–60 min (IV bolus); prolonged with infusion | | **Histamine release** | Yes (dose-dependent) | Minimal to none | ### Clinical Implications **High-Yield:** Morphine's active metabolites (particularly morphine-6-glucuronide, M6G) are renally cleared. In renal impairment, these accumulate and cause prolonged analgesia and respiratory depression — a major concern in ICU and perioperative settings. **Clinical Pearl:** Fentanyl is preferred in renal failure because its metabolites are inactive and hepatically cleared. Conversely, morphine should be used cautiously or avoided in patients with significant renal dysfunction (eGFR < 30 mL/min). **Warning:** The common misconception is that morphine is "safer" because it is more familiar. In fact, renal-dependent clearance of M6G makes morphine riskier in renal failure. ### Why This Matters in Anesthesia 1. **Dosing adjustments:** Morphine requires dose reduction in renal failure; fentanyl does not. 2. **Drug selection:** Fentanyl is preferred in patients with renal dysfunction, sepsis, or ICU settings where organ function is uncertain. 3. **Accumulation risk:** Morphine accumulation can occur with repeated dosing in renal failure, leading to delayed recovery and prolonged respiratory depression. [cite:KD Tripathi 8e Ch 31]